UK Seeks To Make Clinical Trial Transparency 'Second Nature' For Sponsors

The UK's Health Research Authority says there is no one reason why registration of clinical trials and reporting of results continue to fall short of requirements. It has issued proposals to bring about significant improvements.

PS1809_Clinical Trial_303308024_1200.jpg
The HRA Is Seeking To Improve Research Transparency • Source: Shutterstock

The UK's Health Research Authority is inviting feedback on wide-ranging proposals that seek to ensure that transparency and openness become "second nature" for drug and medical device sponsors who conduct research in the country.

The proposals relate to the HRA’s new “Make It Public" strategy document, which covers all types research involving people, their tissue or personal data, but its initial focus is on...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe